Clinical trial NCT02914652 - References

Ventricular Septal Defect — The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.

Citation(s)

•   Baker JG
  The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. Br J Pharmacol. 2010 Jul;160(5):1048-61. doi: 10.1111/j.1476-5381.2010.00754.x.
•   Binkhorst M, van de Belt T, de Hoog M, van Dijk A, Schokking M, Hopman M
  Exercise capacity and participation of children with a ventricular septal defect. Am J Cardiol. 2008 Oct 15;102(8):1079-84. doi: 10.1016/j.amjcard.2008.05.063. Epub 2008 Jul 26.
•   Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ
  Follow-up after surgical closure of congenital ventricular septal defect. Eur J Cardiothorac Surg. 2003 Oct;24(4):511-5.
•   Cumming GR
  Maximal exercise capacity of children with heart defects. Am J Cardiol. 1981 Jun;47(6):1381.
•   Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) Working Group
  Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011 Mar 1;123(8):841-9. doi: 10.1161/CIRCULATIONAHA.110.958405. Epub 2011 Feb 14.
•   Heiberg J, Laustsen S, Petersen AK, Hjortdal VE
  Reduced long-term exercise capacity in young adults operated for ventricular septal defect. Cardiol Young. 2015 Feb;25(2):281-7. doi: 10.1017/S1047951113002084. Epub 2013 Nov 21.
•   Heiberg J, Petersen AK, Laustsen S, Hjortdal VE
  Abnormal ventilatory response to exercise in young adults operated for ventricular septal defect in early childhood: A long-term follow-up. Int J Cardiol. 2015 Sep 1;194:2-6. doi: 10.1016/j.ijcard.2015.05.071. Epub 2015 May 15.
•   Heiberg J, Ringgaard S, Schmidt MR, Redington A, Hjortdal VE
  Structural and functional alterations of the right ventricle are common in adults operated for ventricular septal defect as toddlers. Eur Heart J Cardiovasc Imaging. 2015 May;16(5):483-9. doi: 10.1093/ehjci/jeu292. Epub 2014 Dec 31.
•   Heiberg J, Schmidt MR, Redington A, Hjortdal VE
  Disrupted right ventricular force-frequency relationships in adults operated for ventricular septal defect as toddlers: abnormal peak force predicts peak oxygen uptake during exercise. Int J Cardiol. 2014 Dec 20;177(3):918-24. doi: 10.1016/j.ijcard.2014.10.009. Epub 2014 Oct 28.
•   Hövels-Gürich HH, Konrad K, Skorzenski D, Nacken C, Minkenberg R, Messmer BJ, Seghaye MC
  Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy. Ann Thorac Surg. 2006 Mar;81(3):958-66.
•   Kindermann W
  Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes? Sports Med. 2007;37(2):95-102. Review.
•   Lehmann S, Bakke PS, Eide GE, Gulsvik A
  Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. Respir Med. 2007 Jun;101(6):1183-90. Epub 2006 Dec 22.
•   Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L
  Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007 Jan 16;115(2):163-72. Epub 2007 Jan 8.
•   Meijboom F, Szatmari A, Utens E, Deckers JW, Roelandt JR, Bos E, Hess J
  Long-term follow-up after surgical closure of ventricular septal defect in infancy and childhood. J Am Coll Cardiol. 1994 Nov 1;24(5):1358-64.
•   Menting ME, Cuypers JA, Opic P, Utens EM, Witsenburg M, van den Bosch AE, van Domburg RT, Meijboom FJ, Boersma E, Bogers AJ, Roos-Hesselink JW
  The unnatural history of the ventricular septal defect: outcome up to 40 years after surgical closure. J Am Coll Cardiol. 2015 May 12;65(18):1941-51. doi: 10.1016/j.jacc.2015.02.055.
•   Morton AR, Joyce K, Papalia SM, Carroll NG, Fitch KD
  Is salmeterol ergogenic? Clin J Sport Med. 1996 Oct;6(4):220-5.
•   Norozi K, Gravenhorst V, Hobbiebrunken E, Wessel A
  Normality of cardiopulmonary capacity in children operated on to correct congenital heart defects. Arch Pediatr Adolesc Med. 2005 Nov;159(11):1063-8.
•   Norozi K, Wessel A, Alpers V, Arnhold JO, Binder L, Geyer S, Zoege M, Buchhorn R
  Chronotropic incompetence in adolescents and adults with congenital heart disease after cardiac surgery. J Card Fail. 2007 May;13(4):263-8.
•   Ohuchi H, Watanabe K, Kishiki K, Wakisaka Y, Echigo S
  Heart rate dynamics during and after exercise in postoperative congenital heart disease patients. Their relation to cardiac autonomic nervous activity and intrinsic sinus node dysfunction. Am Heart J. 2007 Jul;154(1):165-71.
•   Otterstad JE, Simonsen S, Erikssen J
  Hemodynamic findings at rest and during mild supine exercise in adults with isolated, uncomplicated ventricular septal defects. Circulation. 1985 Apr;71(4):650-62.
•   Penny DJ, Vick GW 3rd
  Ventricular septal defect. Lancet. 2011 Mar 26;377(9771):1103-12. doi: 10.1016/S0140-6736(10)61339-6. Epub 2011 Feb 23. Review.
•   Perrault H, Drblik SP, Montigny M, Davignon A, Lamarre A, Chartrand C, Stanley P
  Comparison of cardiovascular adjustments to exercise in adolescents 8 to 15 years of age after correction of tetralogy of fallot, ventricular septal defect or atrial septal defect. Am J Cardiol. 1989 Jul 15;64(3):213-7.
•   Pieroni DR, Nishimura RA, Bierman FZ, Colan SD, Kaufman S, Sanders SP, Seward JB, Tajik AJ, Wiggins JW, Zahka KG
  Second natural history study of congenital heart defects. Ventricular septal defect: echocardiography. Circulation. 1993 Feb;87(2 Suppl):I80-8.
•   Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, Zwinderman AH, Scholten RJ
  ß2-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials. Sports Med. 2011 Jan 1;41(1):39-57. doi: 10.2165/11537540-000000000-00000. Review.
•   Reybrouck T, Rogers R, Weymans M, Dumoulin M, Vanhove M, Daenen W, Van der Hauwaert L, Gewillig M
  Serial cardiorespiratory exercise testing in patients with congenital heart disease. Eur J Pediatr. 1995 Oct;154(10):801-6.
•   Roos-Hesselink JW, Meijboom FJ, Spitaels SE, Van Domburg R, Van Rijen EH, Utens EM, Bogers AJ, Simoons ML
  Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. Eur Heart J. 2004 Jun;25(12):1057-62.
•   Sulc J, Samánek M, Zapletal A, Vorísková M, Hucín B, Skovránek J
  Lung function in VSD patients after corrective heart surgery. Pediatr Cardiol. 1996 Jan-Feb;17(1):1-6.
•   van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW
  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011 Nov 15;58(21):2241-7. doi: 10.1016/j.jacc.2011.08.025. Review.
•   Vik-Mo H, Halvorsen FJ, Thorsen E, Walde NH, Rosland GA
  Improved cardiac performance by salbutamol, a selective beta 2-agonist, in chronic cor pulmonale. J Cardiovasc Pharmacol. 1987 Feb;9(2):129-34.
•   Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD
  Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001 Apr;37(5):1170-5.

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial

Details for clinical trial NCT02914652